Administration of Lamivudine for Chronic Hepatitis Resulting From Acute HBV Genotype a Infection

Acta Hepatologica Japonica- Japan

doi 10.2957/kanzo.46.506

Full Text

Abstract

Available in

Categories

Date

January 1, 2005

Authors

Takashi IKEHARA

Masao SHINOHARA

Yasukiyo SUMINO

Publisher

Japan Society of Hepatology

Related search

Lamivudine Treatment for Severe Acute HBV Hepatitis

International Journal of Medical Sciences

English

Hepatitis B Surface Antigen Seroclearance During Chronic HBV Infection

Antiviral Therapy

Infectious Diseases

French

Serum HBV RNA: A New Potential Biomarker for Chronic Hepatitis B Virus Infection

English

Lamivudine for the Treatment of Membranous Glomerulopathy Secondary to Chronic Hepatitis B Infection

Canadian Journal of Gastroenterology

English

New Strategy Treating Hepatitis B Virus (HBV) Infection: A Review of HBV Infection Biology

English

Telbivudine (Sebivo) in Patients With Hepatitis B Virus (HBV) Chronic Infection

Farmeconomia. Health economics and therapeutic pathways

English

HBV DNA Suppression and HBsAg Clearance in HBeAg Negative Chronic Hepatitis B Patients on Lamivudine Therapy for Over 5years

Journal of Hepatology

English

Impact of Hepatitis B Virus (HBV) X Gene Mutations on Hepatocellular Carcinoma Development in Chronic HBV Infection

Clinical and Vaccine Immunology

Clinical Biochemistry

English

Serum Sphingolipids Reflect the Severity of Chronic HBV Infection and Predict the Mortality of HBV-Acute-on-Chronic Liver Failure

Multidisciplinary

English